ACME — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Reshape Biotechreshapebiotech.cominApr 2024
Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories.
AI & Machine LearningBiotechDeep TechHealthtechRoboticsCopenhagen, DK
Carl-Emil Grøn Fuglesang(Founder)Magnus Nyborg Madsen(Founder)inDaniel Storgaard(Founder)in
Co-investorsACME CapitalAstanor VenturesFundersClubY CombinatorR7 Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.